Stock screenerAll disclosures →
EDGAR →
NCEL
Conviction 18HealthcareScan · Mon, Aug 10, 2026NCEL$3.31-0.90%
ResistanceSupportVol 14Insider buyVol MA14 9.73K
May 8May 27Jun 15Jul 2Jul 22Aug 7
NewcelX Ltd.www.newcelx.com ↗
Price3.31
Change-0.90%
Gap-1.80%
Rel volume0.30×
Avg volume13.09K
Avg $ vol48.96K
SMA 203.67
SMA 503.58
SMA 200—
Price vs 50-7.44%
Price vs 200—
MA stack—
50/200 cross—
Supertrendup · 3.15
RSI (14)40
MACD hist-0.05
MACD cross—
Stoch %K / %D20 / 26
ADX (14)25
+DI / −DI12 / 19
RSI divergence—
MACD divergence—
ATR %+9.27%
ADR %8.22%
52w high7.29
52w low1.88
From 52w high-54.60%
Above 52w low+76.06%
New 52w highNo
SqueezeOff
Bollinger width26.61%
%B0.13
Donchian pos13.68%
Donchian high4.32
Donchian low3.15
AVWAP (52w high)3.55
vs AVWAP high-6.78%
AVWAP (52w low)3.59
vs AVWAP low-7.89%
OBV trendDown
Chaikin MF (20)-0.15
Today vs 20d0.30×
Avg vol (14d)9.73K
Avg vol (20d)13.09K
Avg $ vol (20d)48.96K
Market cap—
RS 3m (vs SPY)-3.54%
RS 6m (vs SPY)+11.26%
RS line new highNo
Trend template—
Technical rank41.2
1 week-5.16%
1 month-19.85%
3 months+2.16%
6 months+25.38%
1 year—
YTD+58.37%
P/E—
P/B2.21
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq0.05
Current0.76
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value14.18M
Revenue—
Net income—
Gross profit—
Free cash flow—
Industry—
ExchangeNasdaq
Shares out5.35M
Employees4
ListedTue, Jan 26, 2021
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction18 / 100
Pattern quality—
Tech rank41.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance4.48
Support3.12
Days since event—
Candle confirm—
News sentiment—
Congress activity
Disclosed STOCK Act trades in NCEL
No recent disclosed trades by Congress in NCEL. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in NCEL · 4 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Revel Michel CSO and Director · Warrant (right to buy) · 2026-04-27 | Buy | 76.36K | — | 2026-04-27 | 2026-04-29 |
Samuel Olivier Director · Warrant (right to buy) · 2026-04-27 | Buy | 114.55K | — | 2026-04-27 | 2026-04-29 |
Samuel Olivier Director · Common Shares, par value CHF 0.05 per share · 2026-04-27 | Buy | 81.82K | $225K | 2026-04-27 | 2026-04-29 |
Revel Michel CSO and Director · Common Shares, par value CHF 0.05 per share · 2026-04-27 | Buy | 54.55K | $150K | 2026-04-27 | 2026-04-29 |
SEC filings
EDGAR filings in NCEL · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.